Rocket Pharmaceuticals (RCKT) PT Raised to $60 at Piper Sandler After Positive POC Data
Piper Sandler analyst Tyler Van Buren raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $60.00 (from $50.00) after ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)